PlumX Metrics
Embed PlumX Metrics

Pharmacological Profiles of Aspergillomarasmines as Endothelin Converting Enzyme Inhibitors

Japanese Journal of Pharmacology, ISSN: 0021-5198, Vol: 63, Issue: 2, Page: 187-193
1993
  • 28
    Citations
  • 0
    Usage
  • 15
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Aspergillomarasmine-A and-B (AM-A and -B), which were isolated from the cultured broth of an unidentified fungus N877, showed apparent inhibition against endothelin-converting enzyme (ECE) from bovine endothelial cells as measured by the formation of endothelin-1 (ET-1) converted from big endothelin-1 (bET-1), with IC 50 values of 3.4 and 2.5 μ M for AM-A and -B, respectively. EDTA also inhibited ECE (IC 50 =1.1 μ M ), but the inhibitions by AM-A, AM-B and EDTA were each abolished by the addition of 10 μ Μ Zn 2+ to the reaction mixture. In mice, AM-A and -B dose-dependently (10-50 mg/kg, i.v.) caused significant prolongation of the latency to sudden death induced by i.v. bET-1 (25 nmol/kg), but not that by ET-1 (5 nmol/kg), accompanied by a decrease in plasma immunoreactive ET-1 formation, while EDTA (24 mg/kg) failed to do so. In mice, the LD 50 value of AM-A was calculated to be 159.8 mg/kg, i.v., which was much larger than that of EDTA (28.5 mg/kg, i.v.), indicating the low toxicity of AM-A. AM-A (30 mg/kg, i.v.) also suppressed bET-1-induced hemoconcentration and hypertension in mice and rats, respectively. These findings suggest that although ECE inhibition by AM-A was mainly attributable to its chelating activity, it showed apparent in vivo activities due to ECE inhibition with low toxicity.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know